Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 30929252 | HLA-DRB1 (HLA-DRB1) | myasthenia gravis musk | NA | NA | NA | unclassified | |
| relation of hla-drb1 to igg4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (musk-mg). | |||||||
| 16839505 | MHC (MHC) | enterobacterial infections | NA | NA | NA | unclassified | |
| animal models confirmed the primary role of mhc in spa susceptibility and supported the hypothesis that certain enterobacterial infections can trigger spa. | |||||||
| 27833611 | HLA MISMATCHED (HLA-MISMATCHED) | lymphoid leukemias | NA | NA | NA | negation | |
| adoptive cell therapy using allogeneic hla-mismatched natural killer (nk) cells has emerged as an effective and safe alternative in the treatment of acute myeloid and lymphoid leukemias that do not respond to traditional therapies. | |||||||
| 23968987 | NA (NA) | chronic inflammatory demyelinating polyradiculoneuropathy | Tunisian | NA | NA | unclassified | |
| association of hla-dr/dq polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in tunisian patients. | |||||||
| 23968987 | HLA-DR (HLA-DR) | chronic inflammatory demyelinating polyradiculoneuropathy | Tunisian | NA | NA | unclassified | |
| association of hla-dr/dq polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in tunisian patients. | |||||||
| 16939910 | HLA (HLA) | diseases blood | NA | NA | NA | unclassified | |
| the two groups were matched for the operation time, gender, age, primary diseases, blood type, pra and hla matching and use of immunosuppressants. | |||||||
| 17013445 | NA (NA) | irritable bowel syndrome | NA | NA | NA | unclassified | |
| positive coeliac serology in irritable bowel syndrome patients with normal duodenal biopsies: video capsule endoscopy findings and hla-dq typing may affect clinical management. | |||||||
| 25970075 | HLA-B*59 | toxic epidermal necrolysis | Japanese American | methazolamide | NA | unclassified | |
| toxic epidermal necrolysis induced by methazolamide in a chinese-korean man carrying hla-b*59:01. | |||||||
| 27096699 | HLA-B*15 | acetazolamide | NA | oxcarbazepine | NA | unclassified | |
| Stevens-Johnson Syndrome | |||||||
| 28383863 | HLA-CLASS II (HLA CLASS II) | toxic epidermal necrolysis | NA | NA | NA | unclassified | |
| [how i explore.... hla class ii by ultrastructure in toxic epidermal necrolysis]. | |||||||
Copyright 2024